Endovia Health Sciences (EDVA) Net Cash Flow (2012 - 2026)
Powered by 
Analysis
Endovia Health Sciences (EDVA) Net Cash Flow (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.50 Bn | 133.65 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 65.05 Bn | 59.86 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.11 Bn | 51.98 Bn | 52.00 Mn | -183.00 Mn |
| 5 | Revolution Medicines | 44.71 Bn | 44.71 Bn | - | 374.50 Mn |
| 6 | BeOne Medicines | 40.40 Bn | 35.31 Bn | 1.53 Bn | 407.41 Mn |
| 7 | Alnylam Pharmaceuticals | 35.36 Bn | 32.05 Bn | 992.69 Mn | -496,000.00 |
| 8 | Royalty Pharma | 28.16 Bn | 27.32 Bn | - | 225.59 Mn |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | -37.14 Mn |
| 10 | Endovia Health Sciences | 801,166.21 | 558,464.21 | - | 63,882.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 63,882.00 |
| Mar 31, 2026 | 123,049.00 |
| Dec 31, 2025 | -13,379.00 |
| Sep 30, 2025 | 204,501.00 |
| Jun 30, 2025 | 145,233.00 |
| Mar 31, 2025 | -52,236.00 |
| Dec 31, 2024 | 239,287.00 |
| Sep 30, 2024 | 363,517.00 |
| Jun 30, 2024 | -6,642.00 |
| Mar 31, 2024 | -357,783.00 |
| Dec 31, 2023 | 291,992.00 |
| Sep 30, 2023 | -836,520.00 |
| Jun 30, 2023 | -1.23 Mn |
| Mar 31, 2023 | -2.28 Mn |
| Dec 31, 2022 | 1.88 Mn |
| Sep 30, 2022 | -1.60 Mn |
| Jun 30, 2022 | -4.06 Mn |
| Mar 31, 2022 | 4.09 Mn |
| Dec 31, 2021 | -3.67 Mn |
| Sep 30, 2021 | -3.82 Mn |